Cathie's Ark Logo
ARKK Holdings/NTLA/
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing

Trades of NTLA Made In ARKK

Why do the number of shares of a company held in an ARK ETF go up or down even when no trades are reported?

The Bucket Report Icon
Trader's Guide 2024Ships December 21st. Download our December Market Report and reserve your copy today.
Date
Direction
Shares
Fund Weight
Fund
November 13, 2023		BUY106.152k0.0358%ARKK
November 10, 2023		BUY6.238k0.0022%ARKK
November 1, 2023		BUY21.751k0.009%ARKK
October 20, 2023		BUY29.319k0.0124%ARKK
October 19, 2023		BUY229.492k0.0967%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
2.9%$2.76b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
13🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
15$62.04
🎫ARK Ownership Percent
8.78%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA